Back to Search Start Over

Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.

Authors :
Zapata-Cobo P
Salvador-Matín S
Velasco M
Palomino LM
Clemente S
Segarra O
Moreno-Álvarez A
Fernández-Lorenzo A
Pérez-Moneo B
Montraveta M
Sánchez C
Tolín M
Loverdos I
Fobelo MJ
Navas-López VM
Magallares L
García-Romero R
Sánchez-Hernández JG
Rodríguez A
Bossacoma F
Balboa MJ
Salcedo E
Sanjurjo-Sáez M
López-Fernández LA
Source :
Pharmacological research [Pharmacol Res] 2023 Oct; Vol. 196, pp. 106938. Date of Electronic Publication: 2023 Sep 23.
Publication Year :
2023

Abstract

Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Details

Language :
English
ISSN :
1096-1186
Volume :
196
Database :
MEDLINE
Journal :
Pharmacological research
Publication Type :
Editorial & Opinion
Accession number :
37748560
Full Text :
https://doi.org/10.1016/j.phrs.2023.106938